118 related articles for article (PubMed ID: 3196011)
1. Macrodilution MBC result reproducibility for methicillin-susceptible and reputedly tolerant Staphylococcus aureus isolates.
Wolfrey BF; Lally RT
Antimicrob Agents Chemother; 1988 Sep; 32(9):1464. PubMed ID: 3196011
[No Abstract] [Full Text] [Related]
2. Oxacillin, cephalothin, and vancomycin tube macrodilution MBC result reproducibility and equivalence to MIC results for methicillin-susceptible and reputedly tolerant Staphylococcus aureus isolates.
Pelletier LL; Baker CB
Antimicrob Agents Chemother; 1988 Mar; 32(3):374-7. PubMed ID: 3364955
[TBL] [Abstract][Full Text] [Related]
3. Lack of reproducibility of macrodilution MBCs for Staphylococcus aureus.
Pelletier LL
Antimicrob Agents Chemother; 1984 Dec; 26(6):815-8. PubMed ID: 6570083
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of fosfomycin against methicillin-susceptible and methicillin-resistant Staphylococcus aureus.
Graninger W; Leitha T; Havel M; Georgopoulos A
Infection; 1984; 12(4):293-5. PubMed ID: 6092279
[TBL] [Abstract][Full Text] [Related]
5. In-vitro activity of methicillin against clinical isolates of Staphylococcus aureus.
Frimodt-Møller N; Hartzen SH; Espersen F
J Antimicrob Chemother; 1985 Feb; 15(2):173-80. PubMed ID: 3156838
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the Cathra inoculating device for susceptibility testing of methicillin-susceptible and methicillin-resistant Staphylococcus aureus strains.
Boyce JM; Bonner MC; Lockwood WR
Antimicrob Agents Chemother; 1982 Nov; 22(5):901-2. PubMed ID: 6924824
[TBL] [Abstract][Full Text] [Related]
7. Epidemiologic distribution of the arginine catabolic mobile element among selected methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolates.
Goering RV; McDougal LK; Fosheim GE; Bonnstetter KK; Wolter DJ; Tenover FC
J Clin Microbiol; 2007 Jun; 45(6):1981-4. PubMed ID: 17409207
[TBL] [Abstract][Full Text] [Related]
8. In vitro activities of teichomycin, fusidic acid, flucloxacillin, fosfomycin, and vancomycin against methicillin-resistant Staphylococcus aureus.
Guenthner SH; Wenzel RP
Antimicrob Agents Chemother; 1984 Aug; 26(2):268-9. PubMed ID: 6237606
[TBL] [Abstract][Full Text] [Related]
9. In-vitro activity of paldimycin against methicillin-resistant and susceptible isolates of Staphylococcus aureus and S. epidermidis.
Pfaller MA; Bale M; Barrett M
J Antimicrob Chemother; 1987 Aug; 20(2):286-8. PubMed ID: 3667485
[No Abstract] [Full Text] [Related]
10. In vitro susceptibility of methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains to N-formimidoyl thienamycin.
Witte JL; Sapico FL; Canawati HN
Antimicrob Agents Chemother; 1982 Nov; 22(5):906-8. PubMed ID: 6960806
[TBL] [Abstract][Full Text] [Related]
11. Methicillin-resistant Staphylococcus aureus susceptibility testing by an automated system, Autobac I.
Cleary TJ; Maurer D
Antimicrob Agents Chemother; 1978 May; 13(5):837-41. PubMed ID: 248270
[TBL] [Abstract][Full Text] [Related]
12. Staphylococcal cassette chromosome mec (SCCmec) and characterization of the attachment site (attB) of methicillin resistant Staphylococcus aureus (MRSA) and methicillin susceptible Staphylococcus aureus (MSSA) isolates.
Bitrus AA; Zunita Z; Khairani-Bejo S; Othman S; Ahmad Nadzir NA
Microb Pathog; 2018 Oct; 123():323-329. PubMed ID: 30053600
[TBL] [Abstract][Full Text] [Related]
13. The 'borderline methicillin-susceptible' Staphylococcus aureus.
Varaldo PE
J Antimicrob Chemother; 1993 Jan; 31(1):1-4. PubMed ID: 8444653
[No Abstract] [Full Text] [Related]
14. Screening method for recovery of methicillin-resistant Staphylococcus aureus from primary plates.
La Zonby JG; Starzyk MJ
J Clin Microbiol; 1986 Aug; 24(2):186-8. PubMed ID: 3091633
[TBL] [Abstract][Full Text] [Related]
15. Activity of ciprofloxacin against methicillin-resistant Staphylococcus aureus.
Smith SM; Eng RH
Antimicrob Agents Chemother; 1985 May; 27(5):688-91. PubMed ID: 3160301
[TBL] [Abstract][Full Text] [Related]
16. Widespread quinolone resistance among methicillin-resistant Staphylococcus aureus isolates in a general hospital.
Shalit I; Berger SA; Gorea A; Frimerman H
Antimicrob Agents Chemother; 1989 Apr; 33(4):593-4. PubMed ID: 2729953
[TBL] [Abstract][Full Text] [Related]
17. Comparative in vitro inhibitory and killing activity of cefpirome, ceftazidime, and cefotaxime against Pseudomonas aeruginosa, enterococci, Staphylococcus epidermidis, and methicillin-susceptible and -resistant and tolerant and nontolerant Staphylococcus aureus.
Goldstein EJ; Citron DM
Antimicrob Agents Chemother; 1985 Jul; 28(1):160-2. PubMed ID: 3929677
[TBL] [Abstract][Full Text] [Related]
18. Environmental regulation of biofilm development in methicillin-resistant and methicillin-susceptible Staphylococcus aureus clinical isolates.
Fitzpatrick F; Humphreys H; O'Gara JP
J Hosp Infect; 2006 Jan; 62(1):120-2. PubMed ID: 16221507
[No Abstract] [Full Text] [Related]
19. Detection of intrinsically resistant (heteroresistant) Staphylococcus aureus with the Sceptor and AutoMicrobic systems.
Hansen SL; Walsh TJ
J Clin Microbiol; 1987 Feb; 25(2):412-5. PubMed ID: 3643928
[TBL] [Abstract][Full Text] [Related]
20. Synergism between vancomycin and gentamicin or tobramycin for methicillin-susceptible and methicillin-resistant Staphylococcus aureus strains.
Watanakunakorn C; Tisone JC
Antimicrob Agents Chemother; 1982 Nov; 22(5):903-5. PubMed ID: 6924825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
